Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Schmitz's Stock Ratings
Guggenheim Analyst
Michael Schmitz is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/23/2025
Overall Average Return
-3.12%
Smart Score
Overall Average Return Percentile
30th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/28/2024 | RVMD | Buy Now | Revolution Medicines | $38.53 | 112.82% | Michael Schmitz44% | $72 → $82 | Maintains | Buy | Get Alert |
| 10/01/2024 | MRUS | Buy Now | Merus | $53.48 | 107.53% | Michael Schmitz44% | $93 → $111 | Maintains | Buy | Get Alert |
| 08/02/2024 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 37.68% | Michael Schmitz44% | $130 → $138 | Maintains | Buy | Get Alert |
| 05/28/2024 | MRUS | Buy Now | Merus | $53.48 | 73.88% | Michael Schmitz44% | $57 → $93 | Maintains | Buy | Get Alert |
| 11/20/2023 | ARVN | Buy Now | Arvinas | $6.31 | 533.91% | Michael Schmitz44% | → $40 | Upgrade | Neutral → Buy | Get Alert |
| 02/28/2023 | RVMD | Buy Now | Revolution Medicines | $38.53 | -1.38% | Michael Schmitz44% | → $38 | Reiterates | → Buy | Get Alert |
| 01/03/2023 | FATE | Buy Now | Fate Therapeutics | $1.17 | — | Michael Schmitz44% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $100.23 | -15.2% | Michael Schmitz44% | $110 → $85 | Maintains | Buy | Get Alert |
| 01/03/2022 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 21.72% | Michael Schmitz44% | $120 → $122 | Maintains | Buy | Get Alert |
| 11/29/2021 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 19.72% | Michael Schmitz44% | $122 → $120 | Maintains | Buy | Get Alert |
| 10/28/2021 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 21.72% | Michael Schmitz44% | $120 → $122 | Maintains | Buy | Get Alert |
| 08/10/2021 | IMGO | Buy Now | Imago BioSciences | — | — | Michael Schmitz44% | → $35 | Initiates | → Buy | Get Alert |
| 04/29/2021 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 9.75% | Michael Schmitz44% | $125 → $110 | Maintains | Buy | Get Alert |
| 10/29/2020 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 19.72% | Michael Schmitz44% | $106 → $120 | Maintains | Buy | Get Alert |
| 09/23/2020 | BPMC | Buy Now | Blueprint Medicines | $100.23 | 5.76% | Michael Schmitz44% | $94 → $106 | Maintains | Buy | Get Alert |
| 01/06/2020 | NOVA | Buy Now | Sunnova Energy Intl | $0.19 | 7966.68% | Michael Schmitz44% | → $15 | Initiates | → Buy | Get Alert |
| 03/16/2018 | EEQ | Buy Now | Enbridge Energy | — | — | Michael Schmitz44% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/16/2018 | EEP | Buy Now | Enbridge Energy Partners | — | — | Michael Schmitz44% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/30/2017 | AMGP | Buy Now | Antero Midstream GP | — | — | Michael Schmitz44% | → $27 | Initiates | → Buy | Get Alert |
| 01/20/2017 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | → $61 | Initiates | → Neutral | Get Alert |
| 12/19/2016 | APC | Buy Now | Anadarko Petroleum | — | — | Michael Schmitz44% | → $85 | Initiates | → Buy | Get Alert |
| 12/19/2016 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | → $80 | Initiates | → Buy | Get Alert |
| 11/01/2016 | EEQ | Buy Now | Enbridge Energy Management LLC Shares repstg limited liability company interests | — | — | Michael Schmitz44% | — | Assumes | → Buy | Get Alert |
| 11/01/2016 | EEP | Buy Now | Enbridge Energy, L.P. Class A Common Units | — | — | Michael Schmitz44% | — | Assumes | → Buy | Get Alert |
| 07/13/2016 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | — | Initiates | → Buy | Get Alert |
| 05/06/2016 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | $52 → $54 | Downgrade | Buy → Neutral | Get Alert |
| 11/11/2015 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | — | Upgrade | Neutral → Buy | Get Alert |
| 10/16/2014 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | → $90 | Upgrade | → Buy | Get Alert |
| 05/01/2014 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/11/2014 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | $71 → $74 | Downgrade | Buy → Neutral | Get Alert |
| 02/10/2014 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | → $54 | Upgrade | Neutral → Buy | Get Alert |
| 02/06/2014 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | $64 → $71 | Upgrade | Neutral → Buy | Get Alert |
| 11/04/2013 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | — | Downgrade | → Neutral | Get Alert |
| 08/08/2013 | MMP | Buy Now | Magellan Midstream | — | — | Michael Schmitz44% | $55 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 07/25/2013 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | → $51 | Downgrade | Buy → Neutral | Get Alert |
| 05/30/2013 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | $48 → $51 | Upgrade | Neutral → Buy | Get Alert |
| 03/11/2013 | TCP | Buy Now | TC Pipelines | — | — | Michael Schmitz44% | → $48 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2012 | EEQ | Buy Now | Enbridge Energy Management | — | — | Michael Schmitz44% | $36 → $35 | Maintains | Buy | Get Alert |
| 05/02/2012 | EEP | Buy Now | Enbridge Energy Partners Class A | — | — | Michael Schmitz44% | $36 → $35 | Maintains | Buy | Get Alert |
| 03/12/2012 | MMP | Buy Now | Magellan Midstream Partners | — | — | Michael Schmitz44% | → $75 | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2012 | MMP | Buy Now | Magellan Midstream Partners | — | — | Michael Schmitz44% | $67.5 → $75 | Upgrade | Neutral → Buy | Get Alert |
